BIO Announces Takeda President to Present Keynote at BIO Asia Partnering Conference 2009

WASHINGTON, D.C. (Monday, December 01, 2008) - The Biotechnology Industry Organization (BIO) is pleased to announce that Yasuchika Hasegawa, President of Takeda Pharmaceutical Company Limited, will be Monday’s keynote luncheon speaker for the sixth annual Bio® Asia Partnering Conference, Jan. 19-20, 2009, at the Grand Hyatt Tokyo in Japan. 

“We are honored to have Yasuchika Hasegawa serve as a Bio®Asia 2009 keynote speaker and share his vision for how Takeda will become a global biopharmaceutical leader,” said Jim Greenwood, President and CEO of BIO.  “As one of the key leaders in our space, we look forward to Mr. Hasegawa’s discussion regarding Takeda’s strategic approach in its business.” 

“As Takeda continues to make progress on becoming a world-class pharmaceutical company, we have been fortunate to establish a number of strong collaborations with exceptional partners,” said Yasuchika Hasegawa, President of Takeda Pharmaceutical Company Limited.  “I am honored to have an opportunity to speak at Bio®Asia 2009, as it is an excellent platform for us to meet again with our current partners and build relationships with our partners of the future.”

Mr. Hasegawa began his career at Takeda in 1970 and gained considerable international experience when working for the company in Germany for three years and in Executive level roles in the US for 10 more years. Mr. Hasegawa became a member of the Company’s Board in 1999, helping to focus the company’s operations on its core pharmaceutical operations.  He became President of Takeda Pharmaceutical Company Limited in June 2003 and since that time has successfully overseen the further growth and internationalization of the company, as well as its increasing presence in the biotechnology field.

BIO Asia is an exclusive, customized partnering forum that brings together Asian-Pacific, North American and European biotechnology and pharmaceutical companies interested in research collaborations and licensing agreements.  The event features private, pre-arranged one-on-one meetings between senior-level executives and provides a number of ways to explore a range of international partnering and licensing opportunities.  Over the course of two days, BIO Asia 2009 is expected to host more than 1,500 private meetings and provide numerous formal and informal networking opportunities.  BIO-Asia 2008 attracted more than 550 professionals from more than 325 companies and 26 countries around the world. 

BIO brings more than ten years of experience and expertise in biotech and pharmaceutical partnering to the Asia-Pacific region, after successfully establishing the largest partnering-focused events in the U.S. and Europe.

For registration and information, please visit  Media registration is complimentary to credentialed members of the media.  Please contact for media registration details.  If you have any questions, please contact


Upcoming BIO Events

BIO-Asia Partnering Conference 2009
January 19-20, 2009
Tokyo, Japan

BIO CEO & Investor Conference 2009
February 9-10, 2009
New York, New York

BIO-Europe Spring
March 16-18, 2009
Milan, Italy

BIO Windhover 2009
April 13-15, 2009
New York, New York

2009 BIO International Convention
May 18-21, 2009
Atlanta, Ga. 

BioEquity Europe
June 9-10, 2009
Munich, Germany

World Congress on Industrial Biotechnology & Bioprocessing
July 19-22, 2009
Montreal, Quebec, Canada


About BIO

BIO represents more than 1,200 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world.

About Takeda Pharmaceutical Company Limited

Located in Osaka, Japan, Takeda is a research-based global company with its main focus on pharmaceuticals. As the largest pharmaceutical company in Japan and one of the global leaders of the industry, Takeda is committed to striving toward better health for individuals and progress in medicine by developing superior pharmaceutical products. Additional information about Takeda is available through its corporate Web site,